| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $5.03M | - | |
| Other | 21.6K | $1.43M | - | |
| Other | 15.4K | $1.02M | -5,538 | |
| Dir | 8.0K | $530.5K | - | |
| Dir | 8.0K | $530.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2020 | Chess Robert84 | Director | Sell | 5,500 | $17.75 | $97,625.00 | -1.9% | |
| Sep 21, 2020 | Ajer Jeffrey Robert58 | Director | Sell | 2,250 | $19.74 | $44,415.00 | -10.1% | |
| Sep 17, 2020 | Labrucherie Gil M84 | SVP, COO &CFO | Sell | 2,000 | $19.96 | $39,920.00 | -0.8% | |
| Sep 8, 2020 | Chess Robert84 | Director | Sale+OE | 8,000 | $18.53 | $148,240.00 | -2.8% | |
| Aug 18, 2020 | Labrucherie Gil M84 | SVP, COO &CFO | Sell | 8,245 | $19.67 | $162,199.15 | -1.7% | |
| Aug 17, 2020 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 26,200 | $19.67 | $515,354.00 | -8.1% | |
| Aug 17, 2020 | Wilson Mark Andrew58 | SVP &General Counsel | Sell | 1,529 | $19.67 | $30,075.43 | -2.9% | |
| Aug 17, 2020 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sell | 1,367 | $19.67 | $26,888.89 | -0.8% | |
| Aug 17, 2020 | Robin Howard W58 | President &CEO | Sell | 11,885 | $19.67 | $233,777.95 | -3.2% | |
| Jul 9, 2020 | Greer R Scott | Director | Sale+OE | 15,009 | $25.00 | $375,225.00 | -7.8% |